Astrazeneca ADR buy melinda
Start price
01.09.17
/
50%
€27.23
Target price
23.02.18
€36.08
Performance (%)
14.81%
End price
23.02.18
€30.42
Summary
This prediction ended on 23.02.18 with a price of €30.42. The prediction had a final performance of 14.81%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Astrazeneca ADR | 9.302% | 9.302% | 5.224% | 62.442% |
| iShares Core DAX® | 2.594% | -1.158% | 14.782% | 16.813% |
| iShares Nasdaq 100 | 3.553% | -1.727% | 43.265% | 44.227% |
| iShares Nikkei 225® | 0.687% | -8.354% | 18.454% | 1.361% |
| iShares S&P 500 | 2.209% | -0.942% | 31.361% | 42.812% |
According to melinda what are the pros and cons of Astrazeneca ADR for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Astrazeneca ADR diskutieren
Tersera bei Prostatakrebs
Roflumilast Tablette; Oral EXTRA-8 Astrazeneca Pharms Efficiency Approved
2017.08.31
Roflumilast Tablette; Oral EXTRA-8 Astrazeneca Pharms Efficiency Approved
genehmigt
Staaten und Kanada, ein injizierbares Luteinisierendes von Releasing - Hormon - Agonisten zur Behandlung von Krebs - Zeneca hat sich mit TerSera Therapeutics für kommerzielle Rechte Zoladex (Goserelin Acetat Implantat) in den Vereinigten erreicht Prostata, Brustkrebs und bestimmte gutartige gynäkologische Erkrankungen.
(Vom Mitglied beendet)
Stopped prediction by melinda for Astrazeneca ADR
Astrazeneca ADR
Start price
Target price
Perf. (%)
€49.00
29.11.21
29.11.21
-
29.11.22
29.11.22
29.80%
30.11.22
30.11.22
Could be worthwhile Investment >10% per year
Astrazeneca ADR
Start price
Target price
Perf. (%)
€45.60
19.01.20
19.01.20
€55.00
04.11.21
04.11.21
21.49%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Astrazeneca ADR
Start price
Target price
Perf. (%)
€30.19
01.09.17
01.09.17
€40.00
23.02.18
23.02.18
14.81%
23.02.18
23.02.18
Could be worthwhile Investment >10% per year
Astrazeneca ADR
Start price
Target price
Perf. (%)
€26.14
20.02.17
20.02.17
€31.57
13.04.17
13.04.17
3.92%
13.04.17
13.04.17
Could be worthwhile Investment >10% per year
Astrazeneca ADR
Start price
Target price
Perf. (%)
€19.12
10.07.10
10.07.10
€25.00
13.09.10
13.09.10
6.48%
13.09.10
13.09.10
Could be worthwhile Investment >10% per year